about
Oxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosisCirculating levels of plasminogen and oxidized phospholipids bound to plasminogen distinguish between atherothrombotic and non-atherothrombotic myocardial infarction.Oxidized phospholipids are present on plasminogen, affect fibrinolysis, and increase following acute myocardial infarction.In vivo detection of oxidation-specific epitopes in atherosclerotic lesions using biocompatible manganese molecular magnetic imaging probesPeptide mimotopes of malondialdehyde epitopes for clinical applications in cardiovascular disease.Lipoprotein(A) with An Intact Lysine Binding Site Protects the Retina From an Age-Related Macular Degeneration Phenotype in Mice (An American Ophthalmological Society Thesis).Release and capture of bioactive oxidized phospholipids and oxidized cholesteryl esters during percutaneous coronary and peripheral arterial interventions in humans.Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesionsAcute and long-term effect of percutaneous coronary intervention on serially-measured oxidative, inflammatory, and coagulation biomarkers in patients with stable anginaDrug treatment of chronic heart failure in the elderly.Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a).Discordant cardiac biomarker levels independently predict outcome in ST-segment elevation myocardial infarction.Predictors of early readmission or death in elderly patients with heart failure.Post-thienopyridine platelet response, cardiovascular outcomes, and personalized therapy: En attendant Godot.Antisense oligonucleotide lowers plasma levels of apolipoprotein (a) and lipoprotein (a) in transgenic mice.Collagen plug vascular closure devices and reduced risk of bleeding with bivalirudin versus heparin plus abciximab in patients undergoing percutaneous coronary intervention for non st-segment elevation myocardial infarction.Stent thrombosis up to 3 years after stenting for ST-segment elevation myocardial infarction versus for stable angina--comparison of the effects of drug-eluting versus bare-metal stents.Cardiovascular management of cancer patients with chemotherapy-associated left ventricular systolic dysfunction in real-world clinical practice.Assessment of left atrial functional parameters using a novel dedicated analysis tool for real-time three-dimensional echocardiography: validation in comparison to magnetic resonance imaging.Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET.Longitudinal compression of the platinum-chromium everolimus-eluting stent during coronary implantation: predisposing mechanical properties, incidence, and predictors in a large patient cohort.Functional assessment of the left atrium by real-time three-dimensional echocardiography using a novel dedicated analysis tool: initial validation studies in comparison with computed tomography.Relationship between the resting heart rate and the extent of coronary artery disease as assessed by myocardial perfusion SPECT.[Blood pressure limits--the lower, the better?].Percutaneous retrieval of a twisted guide catheter using a longer second radial sheath.Second diastolic pulmonary venous flow and isolated late diastolic mitral valve regurgitation in first-degree atrioventricular block.Dynamic Assessment of Right Ventricular Volumes and Function by Real-Time Three-Dimensional Echocardiography: A Comparison Study With Magnetic Resonance Imaging in 100 Adult PatientsSinus arrest with prolonged asystole due to the trigeminocardiac reflex during application of local anaesthetic in the nasal mucosaTicagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, op
P50
Q26822962-772E0704-FD1D-4B4B-8BCD-40DAE8F1A7D9Q33597486-23326A8B-8F5F-49EC-B28A-586AE40BDB5CQ35905628-28317D3E-456A-4861-8BFB-447744BC2C38Q35905632-CF08B2DA-4E56-4AFC-8147-621BAECA5DA5Q36020265-2DB45883-10E2-45BC-A6DA-FC13F1C15D47Q36148940-D02B3476-6BB8-460D-868B-9DE73B3FDFB4Q36239453-7F39E8C7-24F0-4AB7-88DF-3908EA870F01Q36387263-BB0F9F24-517D-40E5-9927-9F253E623918Q36739679-BCF341D9-2726-4AB9-98B7-AEE8F598DE4CQ37004476-39A107C7-DCBD-40F3-BE38-5DA50E3D6734Q37163064-5E179D80-9887-4716-B9C6-2DA1B58B4D1DQ41127956-5B705D6E-26F4-40C9-A4C5-8BEC84C83EC9Q42943895-F4D8690C-8421-457D-8DA4-D71EB3ABD70AQ42970465-38641D38-4497-4224-92D7-C554B8C2F604Q43922953-6388CA5F-ED84-4762-B5D4-5920D06D9161Q44901932-0ECC0748-2E92-482F-8C00-DED07635A49BQ45924821-C2F76C3E-9420-4497-98D3-7FE506A43AB7Q46056393-4A9DA1DB-A9AB-4AFB-9CE7-3F704AACC022Q46129544-BC6A9365-F603-4A91-9D67-CC9DF6279CCAQ47216094-182D9350-C19A-4844-8F2F-0F71FD185615Q47771413-CB14E152-E544-4B8F-BC2B-AB39FFF9BDFEQ51556590-68E0B6D9-8198-43AE-BCED-B20AA16E7655Q53147071-AE6FB2CB-ACCA-4040-8423-79EC5FAA4093Q53458665-EE349F1C-4735-45FB-8EA7-F6C1FFF0E958Q53663740-123A8EA0-A1F8-4630-94D5-2529EC80B92BQ54708915-CBF83611-33F9-43C3-B84D-D6433C40A5EDQ57779192-FC6F6452-A248-4C90-AC87-4EAB9222E98EQ58551496-FA6DFC54-D969-4CB5-A44C-A04048A621C8Q62590239-027F9E99-FFBE-4D97-9ADC-105DCBE1F681
P50
name
Gregor Leibundgut
@en
Gregor Leibundgut
@nl
type
label
Gregor Leibundgut
@en
Gregor Leibundgut
@nl
prefLabel
Gregor Leibundgut
@en
Gregor Leibundgut
@nl